ANTIMICROBIAL PEPTIDE MPX ALLEVIATES THE LETHAL ATTACK OF ESCHERICHIA COLI IN MICE
Abstract
Escherichia coli is an important zoonotic pathogen causing intestinal diseases. In recent years, due to the unreasonable use of antibiotics, the drug resistance of bacteria has been increasing, and the proportion of multi-drug resistant strains has also been rising, which directly threatens the health of animals and humans. 80% of E. coli are multi-drug resistant strains, with strong resistance to aminoglycosides, sulfonamides, tetracyclines, and chloramphenicol. E. coli is extremely harmful and difficult to control. Therefore, there is an urgent need to find new antibacterial drugs that against E. coli infection and not easy to develop drug resistance. Antimicrobial peptides are a type of small molecule peptides that can resist the invasion of pathogenic microorganisms into the body. They are an important part of the innate immune system. With their small molecular weight, good water solubility, and resistance to resistance, they are considered the best alternative to antibiotics and become a research hotspot in recent years. The antimicrobial peptide MPX was isolated from wasp venom and had better antibacterial activity against both Gram-positive and Gram-negative bacteria. Studies have found that MPX had better bactericidal activity against E. coli in vitro. However, whether MPX also has better bactericidal activity in mice still unknown. In this study, the results found that E. coli infected mice loss of appetite, diarrhea, and grouping together, while MPX treatment significantly alleviated these symptoms. The results of autopsy found that the intestinal congestion, bleeding, thinning of the intestinal wall, yellow viscous fluid in the intestinal cavity, congestion of the lungs, necrosis in the liver, congestion and bleeding of the spleen, and MPX treatment effectively relieved the above symptoms. The qRT-PCR results found that MPX could increase the mRNA expression of the antibacterial protein TFF3 in the jejunum and colon, and reduce the expression of the antibacterial protein Remlβ and REG3γ in the jejunum and colon. H&E staining results further found that MPX could alleviate the pathological damage of mouse intestines and organs caused by E. coli infection. The above results show that MPX has good bactericidal activity against E. coli infection in mice, providing an important reference for the screening of drugs for the clinical treatment of E. coli infection.
References
2. Al, A.S., Padhi, A., Karadottir, H., Morman, C., Graslund, A., Vegvari, A., Johansson, J., Rising, A., Agerberth, B., & Bergman, P. (2021). Citrullination Alters the Antibacterial and Anti-Inflammatory Functions of the Host Defense Peptide Canine Cathelicidin K9CATH In Vitro. J Immunol, 207(3), 974–984. DOI: 10.4049/jimmunol.2001374.
3. Cash, H.L., Whitham, C.V., Behrendt, C.L., & Hooper, L.V. (2006). Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science, 313(5790), 1126–30. DOI: 10.1126/science.1127119.
4. Christa, L., Carnot, F., Simon, M.T., Levavasseur, F., Stinnakre, M.G., Lasserre, C., Thepot, D., Clement, B., Devinoy, E., & Brechot, C. (1996). HIP/PAP is an adhesive protein expressed in hepatocarcinoma, normal Paneth, and pancreatic cells. Am J Physiol, 271(6 Pt 1), G993–1002. DOI: 10.1152/ajpgi.1996.271.6.G993.
5. G, L., Y, R., S, W., X, C., H, X., & Y, S. (2021). Escherichia coliCo-Occurrence of NDM-9 and MCR-1 in a Human Gut Colonized ST1011. Infection and drug resistance, 14(3011–3017). DOI: 10.2147/IDR.S321732.
6. Gallo, R L., & Hooper, L.V. (2012). Epithelial antimicrobial defence of the skin and intestine. Nat Rev Immunol, 12(7), 503–516. DOI: 10.1038/nri3228.
7. Ge, H., Gardner, J., Wu, X., Rulifson, I., Wang, J., Xiong, Y., Ye, J., Belouski, E., Cao, P., Tang, J., Lee, K.J., Coberly, S., Wu, X., Gupte, J., Miao, L., Yang, L., Nguyen, N., Shan, B., Yeh, W C., Veniant, M.M., Li, Y., & Baribault, H. (2015). Trefoil Factor 3 (TFF3) Is Regulated by Food Intake, Improves Glucose Tolerance and Induces Mucinous Metaplasia. PLoS One, 10(6), e0126924. DOI: 10.1371/journal.pone.0126924.
8. Gong, C., Sun, J., Xiao, Y., Qu, X., & Lang, M. (2021). Synthetic Mimics of Antimicrobial Peptides for the Targeted Therapy of Multidrug-Resistant Bacterial Infection. Adv Healthc Mater, e2101244. DOI: 10.1002/adhm.202101244.
9. He, Q., Li, J.K., Li, F., Li, R.G., Zhan, G.Q., Li, G., Du WX, & Tan, H.B. (2015). Mechanism of action of gypenosides on type 2 diabetes and non-alcoholic fatty liver disease in rats. World J Gastroenterol, 21(7), 2058–66. DOI: 10.3748/wjg.v21.i7.2058.
10. M, M., A, B., R, G., F, O., E, P., M, C., F, L., S, C., D, B., K, B., & M, P. (2019). Recovery from mild Escherichia coli O157:H7 infection in young and aged C57BL/6 mice with intact flora estimated by fecal shedding, locomotor activity and grip strength. Comparative immunology, microbiology and infectious diseases, 63(1–9). DOI: 10.1016/j.cimid.2018.12.003.
11. Piyadasa, H., Hemshekhar, M., Osawa, N., Lloyd, D., Altieri, A., Basu, S., Krokhin, O.V., Halayko, A.J., & Mookherjee, N. (2021). Disrupting Tryptophan in the Central Hydrophobic Region Selectively Mitigates Immunomodulatory Activities of the Innate Defence Regulator Peptide IDR-1002. J Med Chem, 64(10), 6696–6705. DOI: 10.1021/acs.jmedchem.0c02065.
12. Roque-Borda, C.A., Pereira, L.P., Guastalli, E., Soares, N.M., Mac-Lean, P., Salgado, D.D., Meneguin, A.B., Chorilli, M., & Vicente, E.F. (2021). HPMCP-Coated Microcapsules Containing the Ctx(Ile(21))-Ha Antimicrobial Peptide Reduce the Mortality Rate Caused by Resistant Salmonella Enteritidis in Laying Hens. Antibiotics (Basel), 10(6), DOI: 10.3390/antibiotics10060616.
13. S, B. (2021). Has resistance to chlorhexidine increased among clinically-relevant bacteria? A systematic review of time course and subpopulation data. PloS one, 16(8), e0256336. DOI: 10.1371/journal.pone.0256336.
14. Santos, B., Alves, E., Ferreira, C.S., Ferreira-Silva, A., Goes-Neto, A., Verly, R.M., Liao, L.M., Oliveira, S.C., & de Magalhaes, M. (2021). Schistocins: Novel antimicrobial peptides encrypted in the Schistosoma mansoni Kunitz Inhibitor SmKI-1. Biochim Biophys Acta Gen Subj, 1865(11), 129989. DOI: 10.1016/j.bbagen.2021.129989.
15. Shang, L., Yu, H., Liu, H., Chen, M., Zeng, X., & Qiao, S. (2021). Recombinant antimicrobial peptide microcin J25 alleviates DSS-induced colitis via regulating intestinal barrier function and modifying gut microbiota. Biomed Pharmacother, 139(111127). DOI: 10.1016/j.biopha.2020.111127.
16. Wlodarska, M., & Finlay, B.B. (2010). Host immune response to antibiotic perturbation of the microbiota. Mucosal Immunol, 3(2), 100-3. DOI: 10.1038/mi.2009.135.
17. X, Z., L, W., C, Z., X, X., S, Z., Y, W., H, Z., Y, X., S, C., J, J., S, L., Y, W., X, W., G, Z., Y, B., H, F., & J, H. (2021). Escherichia coli The Antimicrobial Peptide Mastoparan X Protects Against Enterohemorrhagic O157:H7 Infection, Inhibits Inflammation, and Enhances the Intestinal Epithelial Barrier. Frontiers in microbiology, 12(644887). DOI: 10.3389/fmicb.2021.644887.
18. Xie, Z., Zhao, Q., Wang, H., Wen, L., Li, W., Zhang, X., Lin, W., Li, H., Xie, Q., & Wang, Y. (2020). Effects of antibacterial peptide combinations on growth performance, intestinal health, and immune function of broiler chickens. Poult Sci, 99(12), 6481–6492. DOI: 10.1016/j.psj.2020.08.068.
19. Xiong, B., Zhang, W., Wu, Z., Liu, R., Yang, C., Hui, A., Huang, X., & Xian, Z. (2021). Okra pectin relieves inflammatory response and protects damaged intestinal barrier in caerulein-induced acute pancreatic model. J Sci Food Agric, 101(3), 863–870. DOI: 10.1002/jsfa.10693.
20. YM, B., H, S., & SY, L. (2021). Salt, glucose, glycine, and sucrose protect Escherichia coli O157:H7 against acid treatment in laboratory media. Food microbiology, 100(103854). DOI: 10.1016/j.fm.2021.103854.
21. Zhang, X., Zhao, Q., Wen, L., Wu, C., Yao, Z., Yan, Z., Li, R., Chen, L., Chen, F., Xie, Z., Chen, F., & Xie, Q. (2021). The Effect of the Antimicrobial Peptide Plectasin on the Growth Performance, Intestinal Health, and Immune Function of Yellow-Feathered Chickens. Front Vet Sci, 8(688611). DOI: 10.3389/fvets.2021.688611.
ISSN 
ISSN 
